Inferring the Origin of Metastases from Cancer Phylogenies
Determining the evolutionary history of metastases is a key problem in cancer biology. Several recent studies have presented inferences regarding the origin of metastases based on phylogenies of cancer lineages. Many of these studies have concluded that the observed monophyly of metastatic subclones...
Saved in:
Published in | Cancer research (Chicago, Ill.) Vol. 75; no. 19; pp. 4021 - 4025 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
01.10.2015
|
Subjects | |
Online Access | Get full text |
ISSN | 0008-5472 1538-7445 1538-7445 |
DOI | 10.1158/0008-5472.CAN-15-1889 |
Cover
Summary: | Determining the evolutionary history of metastases is a key problem in cancer biology. Several recent studies have presented inferences regarding the origin of metastases based on phylogenies of cancer lineages. Many of these studies have concluded that the observed monophyly of metastatic subclones favored metastasis-to-metastasis spread (“a metastatic cascade” rather than parallel metastases from the primary tumor). In this article, we argue that identifying a monophyletic clade of metastatic subclones does not provide sufficient evidence to unequivocally establish a history of metastatic cascades. In the absence of a complete phylogeny of the subclones within the primary tumor, a scenario of parallel metastatic events from the primary tumor is an equally plausible interpretation. Future phylogenetic studies on the origin of metastases should obtain a complete phylogeny of subclones within the primary tumor. This complete phylogeny may be obtainable by ultra-deep sequencing and phasing of large sections or by targeted sequencing of many small, spatially heterogeneous sections, followed by phylogenetic reconstruction using well-established molecular evolutionary models. In addition to resolving the evolutionary history of metastases, a complete phylogeny of subclones within the primary tumor facilitates the identification of driver mutations by application of phylogeny-based tests of natural selection. Cancer Res; 75(19); 4021–5. ©2015 AACR. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 order of authorship is alphabetical, indicating equal contributions |
ISSN: | 0008-5472 1538-7445 1538-7445 |
DOI: | 10.1158/0008-5472.CAN-15-1889 |